FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079826 [Registered on: 31/01/2025] Trial Registered Prospectively
Last Modified On: 20/01/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Nutraceutical 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Clinical study on Alkaline water in healthy participants with Alcohol Hangover 
Scientific Title of Study   A Randomized, Controlled, Double Blind clinical study to evaluate use of Hydron Alkaline Ionised Water (HAIW) in healthy participants with Alcohol Hangover 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
HAIW /HANGO/2024/01, Version 1.0, 17th Oct 2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ksheetij Kothari 
Designation  Gastroenterologist Consultant  
Affiliation  Shivam Multispecialty & Accident Care Centre Pvt. Ltd. 
Address  Shivam Multispecialty & Accident Care Centre Pvt. Ltd. Gastroenterology Department, OPD, no. 1o, Ground Floor, Opp. Riverview City, Solapur Pune Hwy,Taravadi, Phursungi, Tal. Haveli Pune

Pune
MAHARASHTRA
412308
India 
Phone  9765180182  
Fax    
Email  ksheetij.kothari@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanjay Tamoli 
Designation  Director 
Affiliation  Target Institute of Medical Education and Research Pvt. Ltd 
Address  Target Institute of Medical Education and Research Pvt. Ltd. Medical Department, A wing, Office 402, 4th Floor, A,B,C Jaswanti Allied Business Center, Ramchandra Lane Extension, Kachpada, Malad West, Mumbai

Mumbai (Suburban)
MAHARASHTRA
400064
India 
Phone  9322522252  
Fax    
Email  targetinstitute@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanjay Tamoli 
Designation  Director 
Affiliation  Target Institute of Medical Education and Research Pvt. Ltd 
Address  Target Institute of Medical Education and Research Pvt. Ltd. Medical Department, A wing, Office 402, 4th Floor, A,B,C Jaswanti Allied Business Center, Ramchandra Lane Extension, Kachpada, Malad West, Mumbai


MAHARASHTRA
400064
India 
Phone  9322522252  
Fax    
Email  targetinstitute@yahoo.com  
 
Source of Monetary or Material Support  
Hydron Alkaline Aqua Pvt. Ltd. 4A, Trust House, 35 Hospital Avenue, Dr E Borges Road, Parel Mumbai 400012 
 
Primary Sponsor  
Name  Hydron Alkaline Aqua Pvt. Ltd.  
Address  4A, Trust House, 35 Hospital Avenue, Dr E Borges Road, Parel Mumbai 400012 
Type of Sponsor  Other [Healthcare Industry] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 3  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhushan Bapusaheb Mogal  Ayurved seva sanghs, Ayurved Mahavidyala,  Dep.of Agadtantra, OPD No. 9, Ground Floor, Ganeshwadi, Nashik, 422003
Nashik
MAHARASHTRA 
9730139911

bhushanbmogal@gmail.com 
Dr Asharani Medidar  Seth Govindji Raoji Ayurved Mahavidyalaya and Hospital, Solapur  Department of Panchakarma OPD no 02, Ground floor, Opp Ayurved College Police Chowky New Budhwar Peth Samrath Chowk, Solapur, Maharashtra 413001
Solapur
MAHARASHTRA 
8830429540

asharani.medidar@sgrayurved.edu.in 
Dr Ksheetij Kothari  Shivam Multispecialty & Accident Care Centre Pvt. Ltd.  Gastroenterology Department, OPD, no. 10, Ground Floor, Opp. Riverview City, Solapur - Pune Hwy, Haveli, Taravadi, Phursungi, Tal. Haveli Pune 412308
Pune
MAHARASHTRA 
9765180182

ksheetij.kothari@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 3  
Name of Committee  Approval Status 
Institutional Ethics Committee Ayurveda Seva Sangh’s, Ayurveda Mahavidyalaya Nashik   Approved 
Institutional Ethics Committee Dr. Mhaske Hospital & Research Centre Pvt. Ltd. Hadapsar, Pune   Approved 
Institutional Ethics Committee Seth Sakharam Nemchand Jain Aushadhalaya Trusts Seth Govindraoji Ayurved Mahavidhya and Seth Sakharam Nemchand Jain Ayurveda Rugnalaya Solapur   Submittted/Under Review 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Alcohol Hangover 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Hydron Alkaline Ionised Water (HAIW)   Subject will be asked to consume HAIW as and even required for 15 days. 
Comparator Agent  Packaged Drinking water  Subject will be asked to consume Packaged Drinking water as and even required for 15 days. 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Literate healthy male and female participants self-reporting to be moderate drinkers of alcohol, which is approximated to usual drinking occasions (corresponding to 2 to 5 or 3 to 7 alcoholic drinks for a 70 kg female and male, respectively, over a 2 to 3 h period) and having any of the symptoms of hangover of mild to moderate severity
2. Participants willing to sign inform consent form
3. A female participant who is of reproductive potential has a negative pregnancy
test and agrees to use contraception throughout study period
 
 
ExclusionCriteria 
Details  1. Subjects being treated for cardiovascular (high blood pressure), immune,
respiratory, endocrine (diabetes), gastrointestinal, liver, biliary tract, kidney
and urinary, nervous, and musculoskeletal system, psychiatric, infectious, and
thyroid diseases, malignant tumors, or a history of peptic ulcer, reflux
esophagitis, or gastrointestinal surgery
2. Pregnant or planning to become pregnant, nursing mothers,
3. Subjects with alcohol use disorder, alcoholism, substance abuse, or were
taking an anti-abuse drug or warfarin, clopidogrel, aspirin, or non-steroidal
anti-inflammatory drugs.
4. Subjects with abnormal creatinine (two times the standard upper limit),
aspartate aminotransferase (AST), or alanine transaminase (ALT) (three times
the standard upper limit) levels.
5. Participants who participated in other interventional clinical trials within 1
month or planned to participate in other interventional clinical trials
6. Participants sensitive or allergic to alkaline water
7. Participants with known history of hepatitis B and or C, diabetes mellitus,
hypertension, cancer
8. Other conditions, which in the opinion of the investigators, makes the participant unsuitable for enrolment or could interfere with his her participation in, and completion of the protocol
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Assessment of Alcohol Hangover Severity Scale (AHSS)  Screening visit (up to 3 days), Baseline visit (Day 0), telephonic follow ups and Day 15  
 
Secondary Outcome  
Outcome  TimePoints 
1. Global assessment for overall change by investigator and by participant
2. Assessment of tolerability of study products by assessing adverse events and
Adverse drug reactions
3. Assessment of adverse events and vitals
 
Screening visit (up to 3 days), Baseline visit (Day 0), telephonic follow ups and Day 15  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   It is a randomized, controlled, double blind clinical study to evaluate use of Hydron Alkaline Ionised Water (HAIW) in healthy participants with Alcohol Hangover. The study will be carried out at 3 to 4 centres in India. As per computer generated randomization list, subjects will be randomized either to HAIW Group or Packaged Drinking Water in 1:1 ratio. Subject will be asked to consume either HAIW or Packaged Drinking water as and even required for 15 days. The primary objectives of the study will be to assess subjects on Alcohol Hangover Severity Scale (AHSS). The secondary objectives of the study will be to assess global assessment for overall change by investigator and by participant, tolerability of study products by assessing adverse events /Adverse drug reactions and adverse events and vitals on screening visit (up to 3 days), Baseline visit (Day 0), telephonic follow ups and Day 15 
Close